The ever-growing range of designer drugs such as selective serotonin reuptake inhibitors (SSRIs) and other new antidepressants, atypical antipsychotic agents, and antiseizure medications may improve treatment efficacy and safety for persons with mood disorders and mental retardation (MR) and autism.
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation
β Scribed by Karin B. Nelson; Judith K. Grether; Lisa A. Croen; James M. Dambrosia; Benjamin F. Dickens; Laura L. Jelliffe; Robin L. Hansen; Terry M. Phillips
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 179 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0364-5134
- DOI
- 10.1002/ana.1024
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Epilepsy and mental retardation, two relatively common childhood conditions, are both associated with a wide range of behavioral disorders. This article reviews the behavioral disturbances found in children with epilepsy, mental retardation, and both conditions. The behavioral disturbances found in
## Abstract We describe a girl with mild facial anomalies, mild mental retardation, and atypical autism with a remarkable behavioral phenotype of persistent anger, aggression, and dysphoria. The occurrence of lateβonset tremor and premature ovarian failure in the maternal branch of the family point